NCT00725543View on ClinicalTrials.gov

Investigation of 9 Consecutive Remicade Infusions in Ankylosing Spondylitis in Austria (Study P04044)(COMPLETED)

CompletedOBSERVATIONAL

Enrollment

358

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions

Spondylitis, Ankylosing

Interventions

BIOLOGICAL

Infliximab

Remicade induction therapy consists of 3 infusions given at weeks 0, 2, and 6 in specialized centers. Maintenance therapy will consist of a maximum of 6 infusions given in doses and intervals due to discretion of physicians.